Identification of ceRNA (lncRNA-miRNA-mRNA) Regulatory Network in Myocardial Fibrosis After Acute Myocardial Infarction

References

• Virani SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke statistics-2020 update: a report from the American heart association. Circulation. 2020;141(9):e139–e596. doi:10.1161/CIR.0000000000000757
   PubMed Web of Science ®Google Scholar
• Zhou B, Yu JW. A novel identified circular RNA, circRNA_010567, promotes myocardial fibrosis via suppressing miR-141 by targeting TGF-β1. Biochem Biophys Res Commun. 2017;487(4):769–775. doi:10.1016/j.bbrc.2017.04.044
   PubMed Web of Science ®Google Scholar
• Chistiakov DA, Orekhov AN, Bobryshev YV. Cardiac-specific miRNA in cardiogenesis, heart function, and cardiac pathology (with focus on myocardial infarction). J Mol Cell Cardiol. 2016;94:107–121. doi:10.1016/j.yjmcc.2016.03.015
   PubMed Web of Science ®Google Scholar
• Wang C, Jing Q. Non-coding RNAs as biomarkers for acute myocardial infarction. Acta Pharmacol Sin. 2018;39(7):1110–1119. doi:10.1038/aps.2017.205
   PubMed Web of Science ®Google Scholar
• Guo Y, Luo F, Liu Q, Xu D. Regulatory non-coding RNAs in acute myocardial infarction. J Cell Mol Med. 2017;21(5):1013–1023. doi:10.1111/jcmm.13032
   PubMed Web of Science ®Google Scholar
• Thum T. Noncoding RNAs and myocardial fibrosis. Nat Rev Cardiol. 2014;11(11):655–663. doi:10.1038/nrcardio.2014.125
   PubMed Web of Science ®Google Scholar
• Luo J, Wu L, Liu D, et al. Gene regulatory network analysis identifies key genes and regulatory mechanisms involved in acute myocardial infarction using bulk and single cell RNA-seq data. Math Biosci Eng. 2021;18(6):7774–7789. doi:10.3934/mbe.2021386
   PubMed Web of Science ®Google Scholar
• Zhuo LA, Wen YT, Wang Y, et al. LncRNA SNHG8 is identified as a key regulator of acute myocardial infarction by RNA-seq analysis. Lipids Health Dis. 2019;18(1):201. doi:10.1186/s12944-019-1142-0
   PubMed Web of Science ®Google Scholar
• Liu X, Xu Y, Deng Y, Li H. MicroRNA-223 regulates cardiac fibrosis after myocardial infarction by targeting RASA1. Cell Physiol Biochem. 2018;46(4):1439–1454. doi:10.1159/000489185
   PubMedGoogle Scholar
• Zoccali C, Bode-Böger S, Mallamaci F, et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet. 2001;358(9299):2113–2117. doi:10.1016/S0140-6736(01)07217-8
   PubMed Web of Science ®Google Scholar
• Valkonen VP, Päivä H, Salonen JT, et al. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet. 2001;358(9299):2127–2128. doi:10.1016/S0140-6736(01)07184-7
   PubMed Web of Science ®Google Scholar
• Zinellu A, Sotgia S, Porcu P, et al. Carotid restenosis is associated with plasma ADMA concentrations in carotid endarterectomy patients. Clin Chem Lab Med. 2011;49(5):897–901. doi:10.1515/CCLM.2011.121
   PubMed Web of Science ®Google Scholar
• Bivona G, Bellia C, Lo Sasso B, et al. Short-term changes in Gal 3 circulating levels after acute myocardial infarction. Arch Med Res. 2016;47(7):521–525. doi:10.1016/j.arcmed.2016.12.009
   PubMed Web of Science ®Google Scholar
• Bivona G, Agnello L, Bellia C, Lo Sasso B, Ciaccio M. Diagnostic and prognostic value of H-FABP in acute coronary syndrome: still evidence to bring. Clin Biochem. 2018;58:1–4. doi:10.1016/j.clinbiochem.2018.04.021
   PubMed Web of Science ®Google Scholar
• Cai Y, Yang Y, Chen X, et al. Circulating ‘lncRNA OTTHUMT00000387022ʹ from monocytes as a novel biomarker for coronary artery disease. Cardiovasc Res. 2016;112(3):714–724. doi:10.1093/cvr/cvw022
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhou C, Qin Q, Liu Z, Li P. LncRNA LEF1-AS1 regulates the migration and proliferation of vascular smooth muscle cells by targeting miR-544a/PTEN axis. J Cell Biochem. 2019;120(9):14670–14678. doi:10.1002/jcb.28728
   PubMed Web of Science ®Google Scholar
• Fridley BL, Dai J, Raghavan R, et al. Transcriptomic characterization of endometrioid, clear cell, and high-grade serous epithelial ovarian carcinoma. Cancer Epidemiol Biomarkers Prev. 2018;27(9):1101–1109. doi:10.1158/1055-9965.EPI-17-0728
   PubMed Web of Science ®Google Scholar
• Zhang L, Chen S, Wang B, et al. An eight-long noncoding RNA expression signature for colorectal cancer patients’ prognosis. J Cell Biochem. 2019;120(4):5636–5643. doi:10.1002/jcb.27847
   PubMed Web of Science ®Google Scholar
• Chen Y, Bi F, An Y, Yang Q. Identification of pathological grade and prognosis-associated lncRNA for ovarian cancer. J Cell Biochem. 2019;120(9):14444–14454. doi:10.1002/jcb.28704
   PubMed Web of Science ®Google Scholar
• Chouvarine P, Legchenko E, Geldner J, Riehle C, Hansmann G. Hypoxia drives cardiac miRNAs and inflammation in the right and left ventricle. J Mol Med. 2019;97(10):1427–1438. doi:10.1007/s00109-019-01817-6
   PubMed Web of Science ®Google Scholar
• McManus DD, Rong J, Huan T, et al. Messenger RNA and MicroRNA transcriptomic signatures of cardiometabolic risk factors. BMC Genom. 2017;18(1):139. doi:10.1186/s12864-017-3533-9
   PubMed Web of Science ®Google Scholar
• Negoro S, Kunisada K, Tone E, et al. Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction. Cardiovasc Res. 2000;47(4):797–805. doi:10.1016/S0008-6363(00)00138-3
   PubMed Web of Science ®Google Scholar
• Mascareno E, El-Shafei M, Maulik N, et al. JAK/STAT signaling is associated with cardiac dysfunction during ischemia and reperfusion. Circulation. 2001;104(3):325–329. doi:10.1161/01.CIR.104.3.325
   PubMed Web of Science ®Google Scholar
• Chen H, Chen Y, Wang X, Yang J, Huang C. Edaravone attenuates myocyte apoptosis through the JAK2/STAT3 pathway in acute myocardial infarction. Free Radic Res. 2020;54(5):351–359. doi:10.1080/10715762.2020.1772469
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang L, Fan X, et al. Captopril attenuates TAC-induced heart failure via inhibiting Wnt3a/β-catenin and Jak2/Stat3 pathways. Biomed Pharmacother. 2019;113:108780. doi:10.1016/j.biopha.2019.108780
   PubMed Web of Science ®Google Scholar
• Chen Y, Surinkaew S, Naud P, et al. JAK-STAT signalling and the atrial fibrillation promoting fibrotic substrate. Cardiovasc Res. 2017;113(3):310–320. doi:10.1093/cvr/cvx004
   PubMed Web of Science ®Google Scholar
• Eid RA, Alkhateeb MA, Eleawa S, et al. Cardioprotective effect of ghrelin against myocardial infarction-induced left ventricular injury via inhibition of SOCS3 and activation of JAK2/STAT3 signaling. Basic Res Cardiol. 2018;113(2):13. doi:10.1007/s00395-018-0671-4
   PubMed Web of Science ®Google Scholar
• Han L, Kong R, Yin DD, et al. Low expression of long noncoding RNA GAS6-AS1 predicts a poor prognosis in patients with NSCLC. Med Oncol. 2013;30(4):694. doi:10.1007/s12032-013-0694-5
   PubMed Web of Science ®Google Scholar
• Zhang P, Dong Q, Zhu H, Li S, Shi L, Chen X. Long non-coding antisense RNA GAS6-AS1 supports gastric cancer progression via increasing GAS6 expression. Gene. 2019;696:1–9. doi:10.1016/j.gene.2018.12.079
   PubMed Web of Science ®Google Scholar
• Ai J, Sun J, Zhou G, Zhu T, Jing L. Long non-coding RNA GAS6-AS1 acts as a ceRNA for microRNA-585, thereby increasing EIF5A2 expression and facilitating hepatocellular carcinoma oncogenicity. Cell Cycle. 2020;19(7):742–757. doi:10.1080/15384101.2020.1729323
   PubMed Web of Science ®Google Scholar
• Zhang PF, Wu J, Luo JH, et al. SNHG22 overexpression indicates poor prognosis and induces chemotherapy resistance via the miR-2467/Gal-1 signaling pathway in epithelial ovarian carcinoma. Aging. 2019;11(19):8204–8216. doi:10.18632/aging.102313
   PubMedGoogle Scholar
• Fang X, Zhang J, Li C, Liu J, Shi Z, Zhou P. Long non-coding RNA SNHG22 facilitates the malignant phenotypes in triple-negative breast cancer via sponging miR-324-3p and upregulating SUDS3. Cancer Cell Int. 2020;20:252. doi:10.1186/s12935-020-01321-9
   PubMed Web of Science ®Google Scholar
• Gao H, Sun X, Wang H, Zheng Y. Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer. Cell Cycle. 2020;19(10):1186–1199. doi:10.1080/15384101.2020.1749466
   PubMed Web of Science ®Google Scholar
• Guo LM, Ding GF, Xu W, et al. MiR-135a-5p represses proliferation of HNSCC by targeting HOXA10. Cancer Biol Ther. 2018;19(11):973–983. doi:10.1080/15384047.2018.1450112
   PubMed Web of Science ®Google Scholar
• Luo W, Sun C, Zhou J, et al. miR-135a-5p functions as a glioma proliferation suppressor by targeting tumor necrosis factor receptor-associated factor 5 and predicts patients’ prognosis. Am J Pathol. 2019;189(1):162–176. doi:10.1016/j.ajpath.2018.08.019
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jiang WL, Yang JY, et al. Downregulation of lysyl oxidase-like 4 LOXL4 by miR-135a-5p promotes lung cancer progression in vitro and in vivo. J Cell Physiol. 2019;234(10):18679–18687. doi:10.1002/jcp.28508
   PubMed Web of Science ®Google Scholar
• Wu Y, Liu Y, Pan Y, et al. MicroRNA-135a inhibits cardiac fibrosis induced by isoproterenol via TRPM7 channel. Biomed Pharmacother. 2018;104:252–260. doi:10.1016/j.biopha.2018.04.157
   PubMed Web of Science ®Google Scholar
• Xu JJ, Zheng WH, Wang J, Chen YY. Long non-coding RNA plasmacytoma variant translocation 1 linked to hypoxia-induced cardiomyocyte injury of H9c2 cells by targeting miR-135a-5p/forkhead box O1 axis. Chin Med J. 2020;133(24):2953–2962. doi:10.1097/CM9.0000000000001147
   PubMed Web of Science ®Google Scholar
• Zhang SX, Garcia-Gras E, Wycuff DR, et al. Identification of direct serum-response factor gene targets during Me2SO-induced P19 cardiac cell differentiation. J Biol Chem. 2005;280(19):19115–19126. doi:10.1074/jbc.M413793200
   PubMed Web of Science ®Google Scholar
• Sannino G, Armbruster N, Bodenhöfer M, et al. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer. Oncotarget. 2016;7(45):73725–73738. doi:10.18632/oncotarget.12455
   PubMedGoogle Scholar
• Huge N, Sandbothe M, Schröder AK, et al. Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma. Hepatol Int. 2020;14(3):373–384. doi:10.1007/s12072-019-09977-w
   PubMed Web of Science ®Google Scholar
• Cantù C, Felker A, Zimmerli D, et al. Mutations in Bcl9 and Pygo genes cause congenital heart defects by tissue-specific perturbation of Wnt/β-catenin signaling. Genes Dev. 2018;32(21–22):1443–1458. doi:10.1101/gad.315531.118
   PubMed Web of Science ®Google Scholar